Return to study ST002097 main page

MB Sample ID: SA201215

Local Sample ID:A549 Non-infection 4
Subject ID:SU002181
Subject Type:Cultured cells
Subject Species:Homo sapiens
Taxonomy ID:9606
Cell Biosource Or Supplier:American Type Culture Collection
Cell Strain Details:A549 (tissue, lung cancer; gender, male), LS174T (tissue, colon cancer; gender, female)
Cell Counts:10,000,000

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU002181
Subject Type:Cultured cells
Subject Species:Homo sapiens
Taxonomy ID:9606
Cell Biosource Or Supplier:American Type Culture Collection
Cell Strain Details:A549 (tissue, lung cancer; gender, male), LS174T (tissue, colon cancer; gender, female)
Cell Counts:10,000,000

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
A549 Non-infection 4SA201215FL024474Non-infectionGenotype/Treatment

Collection:

Collection ID:CO002174
Collection Summary:Cells were collected using trypsin-EDTA. The cells were snap-frozen in liquid nitrogen after cell count, and subsequently stored at -80°C until lipidomic analysis.
Sample Type:Cultured cells
Volumeoramount Collected:10,000,000 cells/tube
Storage Conditions:-80℃

Treatment:

Treatment ID:TR002193
Treatment Summary:Infection of the A549 cell line was carried out by adding viral solution (Ad-Mieap) to A549 cell monolayers, and incubating at 37°C for 120 min with brief agitation every 20 min. This was followed by the addition of culture medium and the return of the infected cells to the 37°C incubator. We established a Mieap-KD cell line using LS174T. Mieap expression was inhibited in the cell line by retroviral expression of short-hairpin RNA (shRNA) against the Mieap sequence. We also established LS174T-cont cells using the retroviral vector with target sequence for EGFP. The LS174T-cont and Mieap-KD cells were incubated under normal condition.
Treatment Doseduration:A549 cells: 24 h; LS174T-cont and Mieap-KD cells: none (incubated under normal condition)
Treatment Vehicle:A549 cells: viral solution (Ad-Mieap); LS174T-cont and Mieap-KD cells: none (incubated under normal condition)
Cell Storage:stored at -80°C

Sample Preparation:

Sampleprep ID:SP002187
Sampleprep Summary:Total lipids were extracted from samples using the Bligh-Dyer method. An aliquot of the organic phase was added to an equal volume of methanol before being loaded onto a DEAE-cellulose column (Wako Chemical) pre-equilibrated with chloroform. After successive washes with chloroform/methanol (1:1, v/v), acidic phospholipids were eluted with chloroform/methanol/HCl/water (12:12:1:1, v/v), followed by evaporation to dryness to yield a residue was soluble in methanol.
Extraction Method:the Bligh-Dyer method

Combined analysis:

Analysis ID AN003425 AN003426 AN003427
Analysis type MS MS MS
Chromatography type Reversed phase Reversed phase Reversed phase
Chromatography system UltiMate 3000 (Thermo Fisher Scientific) Agilent 1290 Infinity Agilent 1290 Infinity
Column Waters X-Bridge C18 (150 x 1.0mm,3.5um) Waters ACQUITY UPLC HSS T3 (100 x 2.1mm,1.8um) Waters ACQUITY UPLC HSS T3 (100 x 2.1mm,1.8um)
MS Type ESI ESI ESI
MS instrument type Orbitrap Triple quadrupole Triple quadrupole
MS instrument name Thermo Q Exactive Plus Orbitrap Agilent 6495 QQQ Agilent 6495 QQQ
Ion Mode NEGATIVE POSITIVE NEGATIVE
Units pmol/10,000,000 cells counts counts

Chromatography:

Chromatography ID:CH002533
Instrument Name:UltiMate 3000 (Thermo Fisher Scientific)
Column Name:Waters X-Bridge C18 (150 x 1.0mm,3.5um)
Chromatography Type:Reversed phase

MS:

MS ID:MS003188
Analysis ID:AN003425
Instrument Name:Thermo Q Exactive Plus Orbitrap
Instrument Type:Orbitrap
MS Type:ESI
MS Comments:pmol/10,000,000 cells
Ion Mode:NEGATIVE
  logo